Alexander Boychenko
Omics Research Lead Bayer Science Fellow @Bayer
Signup · Get unlimited contacts
WORK HISTORY
Omics Research Lead Bayer Science Fellow @Bayer
Wuppertal, DE
Leading Omics Research Laboratory activities within Translational Sciences (TS), part of the Research and Early Development Cardiovascular, Renal, and Immunology (RED CVRI) cluster of the Pharmaceutical Division- Building and managing an efficient, high-performing team of scientists and research associates across Germany and the USA, fostering close collaboration in a Dynamic Shared Ownership environment- Defining strategic directions, setting scientific priorities, and providing guidelines for large-scale multi-omics observational, retrospective, and biobank studies to advance disease understanding, identify new therapeutic targets, and elucidate drug mechanisms of action- Leading Life Science Collaboration (LSC) projects focused on the evaluation and implementation of cutting-edge technologies that enhance translational science applications- Collaborating with strategic key opinion leaders (KOLs) to strengthen scientific insights and drive progress on priority indications.
EDUCATION
V. N. Karazin Kharkiv National University
Master of Science (MSc), Analytical Chemistry
V. N. Karazin Kharkiv National University
Bachelor's degree, Analytical Chemistry
V. N. Karazin Kharkiv National University
Doctor of Philosophy (PhD), Analytical Chemistry
Scientific and Expert Pharmacopoeial Centre, Kharkov, Ukraine
Internship, High-performance liquid chromatography
Université Claude Bernard Lyon 1
Analytical Chemistry
University of Bradford
Analytical Chemistry
University of California, Irvine Division of Continuing Education
Integrated Marketing Program
SKILLS
ABOUT ALEXANDER BOYCHENKO
Leading Omics Research for the Translational Sciences - Research and Early Development Cardiovascular, Renal, and Immunology Cluster, steering large-scale multi-omics studies to drive biomarkers and targets discovery, disease understading and accelerate drug development. I build and mentor high-performing teams across Germany and the US, fostering collaboration within a Dynamic Shared Ownership model. I bridge science and technology by applying deep product and project management, marketing knowledge to the design of high-end scientific instrumentation, guiding the implementation of complex robotized platforms for cutting-edge high-throughput proteomics, metabolomics, and lipidomics phenotyping of human biofluids. My focus is on integrating novel technologies and engaging with strategic KOLs to advance science in priority indications.
This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.